These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 17511797

  • 1. Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
    Jenq CC, Tian YC, Wu HH, Hsu PY, Huang JY, Chen YC, Fang JT, Yang CW.
    Int J Clin Pract; 2008 Mar; 62(3):416-22. PubMed ID: 17511797
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intravenous versus oral iron therapy for postpartum anaemia.
    Bhandal N, Russell R.
    BJOG; 2006 Nov; 113(11):1248-52. PubMed ID: 17004982
    [Abstract] [Full Text] [Related]

  • 6. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE, Lombraña A, Duarte P, Di Gennaro F.
    J Am Coll Cardiol; 2007 Oct 23; 50(17):1657-65. PubMed ID: 17950147
    [Abstract] [Full Text] [Related]

  • 7. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy.
    Khalafallah A, Dennis A, Bates J, Bates G, Robertson IK, Smith L, Ball MJ, Seaton D, Brain T, Rasko JE.
    J Intern Med; 2010 Sep 23; 268(3):286-95. PubMed ID: 20546462
    [Abstract] [Full Text] [Related]

  • 8. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P, Sarafidis PA, Rudenco I, Raptis V, Makedou K, Makedou A, Grekas DM.
    Am J Nephrol; 2007 Sep 23; 27(6):572-9. PubMed ID: 17804904
    [Abstract] [Full Text] [Related]

  • 9. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
    Swarnalatha G, Ram R, Neela P, Naidu MU, Dakshina Murty KV.
    Saudi J Kidney Dis Transpl; 2010 Sep 23; 21(5):852-8. PubMed ID: 20814119
    [Abstract] [Full Text] [Related]

  • 10. IV iron use in patients with higher serum ferritin: case study on anemia in kidney disease.
    Larson K.
    Nephrol Nurs J; 2008 Sep 23; 35(2):184-93; quiz 194-5. PubMed ID: 18472686
    [Abstract] [Full Text] [Related]

  • 11. Comparison of parenteral iron sucrose and ferric chloride during erythropoietin therapy of haemodialysis patients.
    Wu CJ, Lin HC, Lee KF, Chuang CK, Chen YC, Chen HH.
    Nephrology (Carlton); 2010 Feb 23; 15(1):42-7. PubMed ID: 20377770
    [Abstract] [Full Text] [Related]

  • 12. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
    Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT.
    Transfusion; 2009 Dec 23; 49(12):2719-28. PubMed ID: 19682342
    [Abstract] [Full Text] [Related]

  • 13. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC, Hung SC, Tarng DC.
    Am J Kidney Dis; 2006 Jun 23; 47(6):1036-44. PubMed ID: 16731299
    [Abstract] [Full Text] [Related]

  • 14. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J.
    Am J Gastroenterol; 2005 Nov 23; 100(11):2503-9. PubMed ID: 16279906
    [Abstract] [Full Text] [Related]

  • 15. Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial.
    McMahon LP, Kent AB, Kerr PG, Healy H, Irish AB, Cooper B, Kark A, Roger SD.
    Nephrol Dial Transplant; 2010 Mar 23; 25(3):920-6. PubMed ID: 19906658
    [Abstract] [Full Text] [Related]

  • 16. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease.
    Erichsen K, Ulvik RJ, Nysaeter G, Johansen J, Ostborg J, Berstad A, Berge RK, Hausken T.
    Scand J Gastroenterol; 2005 Sep 23; 40(9):1058-65. PubMed ID: 16165718
    [Abstract] [Full Text] [Related]

  • 17. Optimal Serum Ferritin Levels for Iron Deficiency Anemia during Oral Iron Therapy (OIT) in Japanese Hemodialysis Patients with Minor Inflammation and Benefit of Intravenous Iron Therapy for OIT-Nonresponders.
    Takasawa K, Takaeda C, Wada T, Ueda N.
    Nutrients; 2018 Mar 29; 10(4):. PubMed ID: 29596361
    [Abstract] [Full Text] [Related]

  • 18. Minor impairment of oral iron absorption in non-diabetic new dialysis patients.
    Tovbin D, Schnaider A, Vorobiov M, Rogachev B, Basok A, Shull P, Novack V, Friger M, Avramov D, Zlotnik M.
    J Nephrol; 2005 Mar 29; 18(2):174-80. PubMed ID: 15931645
    [Abstract] [Full Text] [Related]

  • 19. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study.
    Lindgren S, Wikman O, Befrits R, Blom H, Eriksson A, Grännö C, Ung KA, Hjortswang H, Lindgren A, Unge P.
    Scand J Gastroenterol; 2009 Mar 29; 44(7):838-45. PubMed ID: 19330567
    [Abstract] [Full Text] [Related]

  • 20. Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease.
    Wikström B, Bhandari S, Barany P, Kalra PA, Ladefoged S, Wilske J, Thomsen LL.
    J Nephrol; 2011 Mar 29; 24(5):589-96. PubMed ID: 21240875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.